A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States.

Daniel J LivorsiMargaret L ChorazyMarin L SchweizerErin C BalkenendeAmy E BlevinsRajeshwari NairMatthew H SamoreRichard E NelsonKarim KhaderEli N Perencevich

Published in: Antimicrobial resistance and infection control (2018)

While the incidence of CRE infections in the United States remains low on a national level, the incidence is highest in LTACs. Studies assessing outcomes in CRE-infected patients are limited in number, small in size, and have reached conflicting results. Future research should measure a variety of clinical outcomes and adequately adjust for confounders to better assess the full burden of CRE.

Keyphrases

risk factors
multidrug resistant
pseudomonas aeruginosa
current status
type diabetes
urinary tract infection
adipose tissue
metabolic syndrome
cystic fibrosis
insulin resistance
skeletal muscle
weight loss